Relationship between Ferritin Levels with Calcium Levels  in Patients  Thalassemia β Major in Hospital in Jember

Fantya Cerebella Aslamy; Rini Riyanti; Cholis Abrori

doi:10.19184/ams.v9i3.31435

Fantya Cerebella Aslamy Faculty of Medicine, University of Jember, Jember, Indonesia
Rini Riyanti 2Department of Clinical Pathology, Faculty of Medicine, University of Jember, Jember, Indonesia
Cholis Abrori Department of Pharmacology, Faculty of Medicine, University of Jember, Jember, Indonesia

DOI: https://doi.org/10.19184/ams.v9i3.31435

Abstract

Thalassemia β major is a hereditary disorder caused by mutations in the β-globin gene, which regulates the formation of one of the components that make up hemoglobin. This disorder results in the production of β-globin chains being reduced or not formed. The prevalence of thalassemia carriers in Indonesia reached 3.8% of the entire population based on data from the Ministry of Health in 2019. Therapy for thalassemia β major patients is lifelong transfusion, which results in iron overload and triggers hypocalcemia and osteoporosis. The aim of this study was to determine the relationship between ferritin levels and calcium levels in thalassemia β major patients. This study uses an observational analytic research type and a cross-sectional research design. This research was conducted at the RSD dr. Soebandi Jember, Jember Clinic Plantation Hospital, and in December 2019-January 2020. The total sample was 13 patients suffering from thalassemia β major aged 1-18 years. The results of the Pearson analysis showed that p=0.858 showed that there was no ignificant correlation between ferritin levels and calcium levels in Thalassemia β major in Jember.

Keywords: Thalassemia β major, ferritin levels, calcium levels, hypocalcemia

References

Aryuliana, D., C. Muslin, S. Manaf, dan E.W. Winarni. 2004. Biologi. Jakarta: Erlangga.
Bulan, S. 2009. Faktor-Faktor yang Berhubungan dengan Kualitas Hidup Anak Thalasemia Beta Mayor. http://www.undip.ac.id. [Diakses pada 27 Februari 2020].
Cappellini, M. D., A. Cohen, J. Porter, A. Taher, dan V. Viprakasit. 2016. Guidelines For The Management of Transfusi Dependent Thalassemia (TDT). Edisi 3. Nicosia: Thalassemia Internasional Federation.
Departemen Kesehatan Republik Indonesia. 2019. Data Pasien Talasemia di Indonesia. www.depkes.org. [Diakses pada 18 September 2019].
El-Nashar, M. 2017. Parathyroid hormone in pediatric patients with β thalassemia major and its relation to bone mineral density; a case control study. The Egyptian Journal of Medical Human Genetics. 18(1): 75-78. http://dx.doi.org/10.1016/j.ejmhg.2016.03.004
Iskandar, N. A., S. Harsono, dan G. M. Annang. 2020. The relationship between ferritin and calcium levels in patients with thalassemia β major. Indonesia Journal ofMedicine.5(2):137-141. https://doi.org/10.26911/theijmed.2020.05.02.07
Kadhim, K. A., K.H. Baldawi, dan F. H. Lami. 2017. Prevalence, incidence, trend, and complications of thalassemia in Iraq. International Journal for Hemoglobin Research. 41(3):164-168. https://doi.org/10.1080/03630269.2017.1354877
Karunaratna, A. M. D. S., Ranasingha, J. G. S., dan Mudiyanse, R. M. 2017. Iron overload in beta thalassemia major patients. International Journal Blood Transfus Immunohematol. 7: 33-40. https://doi.org/10.5348/ijbti-2017-32-OA-5
Langhy Jr, D., E. M. A. Ubiali, J.F.C Marques Jrc, M. de Almeida, S. R. Loggetto, A. Silvinato, dan W. M. Bernardo. 2016. Guidelines on beta thalassemia major – regular blood transfusion therapy. Rev Bras Hematol Hemoter. 38(4): 341-345. http://dx.doi.org/10.1016/j.bjhh.2016.09.003
Li, J., Y. Lin, X. Li, dan J. Zhang. 2019. Economic evaluation of chelation regimens for beta thalassemia major: a systematic review. Mediterranean Journal of Hematology and Infectious Diseases. 11(1). http://dx.doi.org/10.4084/MJHID.2019.036
Marnis, D., G. Indriati, dan F. A. Naul. 2018. Hubungan tingkat pengetahuan ibu dengan kualitas hidup anak thalassemia. Jurnal Keperawatan Sriwijaya. 5(2): 31-42.
Mu’awanah. 2015. Gambaran Status Gizi Pasien Thalassemia di RSUP dr. Kariadi Semarang. Skripsi. Semarang: Universitas Muhammadiyah Semarang.
Nasar, I. M., dan S. Cornain. 2015. Buku Ajar Patologi Robbins. Edisi ke-9. Singapore: Elsevier. Hal: 407.
Neshelli, H. M., dan E. Farahanian. 2016. Relation between bone mineral density and serum ferritin levels in patients with thalassemia major. Caspian Journal of Pediatrics. 2(2): 158-163. http://doi.org/10.22088/acadpub.BUMS.2.2.158
Ozkan, E.A., Z. T. Ozdemir, dan A. N. Akkoca. 2016. The evaluation of bone mineral density in patient with thalassemia major. The Annals of Eurasion Medicine. 4(2): 26-30. http://doi.org/10.1155/2012/573298
Rund, D., dan E. Rachmilewitz. 2005. Beta-Thalassemia. The New England Journal Medicine. 1135-46. http://doi.org/10.1056/NEJMra050436
Safitri, R., J. Ernawaty, dan D. Karim. 2015. Hubungan kepatuhan transfusi dan konsumsi kelasi besi terhadap pertumbuhan anak dengan thalasemia. Jurnal Online Mahasiswa. 2(2): 1474-1483.
Suryani, E., Wiharto, dan N. W. Katarina. 2015. Identifikasi anemia thalassemia beta (β) mayor berdasarkan morfologi sel darah merah. Scientific Journal of Informatics. 2(1): 15-16. http://doi.org/10.15294/sji.v2i1.4525
Shah, N. R. 2017. Advances in Iron Chelation Therapy: Transitioning to a New Oral Formulation. Drugs in Context. 6(21502): 1-10. http://doi.org/10.7573/dic.212502
Taher, A., E. Vichinsky, K. M. Mussalam, M. D. Cappellini, dan V. Viprakasit. 2013. Guidelines for the management of non transfusion dependent thalassaemia (NTDT). Nicosia Thalassemia International Federation.
Tari, K., P. V. Ardalan, M. Abbaszadehdibavar, A. Atashi, A. Jalili, dan M. Gheidishahran. 2018. Thalassemia an update: molecular basis, clinical features and treatment. International Journal BioMed Public Health. 1(1): 48-58. http://doi.org/10.22631/IJBMPH.2018.56102
Wahidiyat, P. A., dan D. I. Stephen. 2018. Pentingnya mempertahankan kadar hemoglobin pra-transfusi tinggi pada pasien thalassemia mayor. E-Journal of Kedokteran Universitas Indonesia. 6(3): 197-199. http://doi.org/10.23886/ejki.6.10142